Literature DB >> 19728502

Should we implement 'opt-out' HIV testing for patients with lymphoma?

J Cave1, S G Edwards, R F Miller, K M Ardeshna, S M Lee.   

Abstract

Patients with HIV are dying due to late diagnosis and physicians are being encouraged to increase HIV testing. The uptake of opt-in HIV screening for 113 lymphoma patients was audited at University College London Hospital. Of the 113 patients, 46 were not tested (41%). Previous research in the antenatal setting suggests that adopting opt-out screening would increase testing rates.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19728502      PMCID： PMC4952496          DOI： 10.7861/clinmedicine.9-4-320

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  9 in total

1.  Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.

Authors:  J T Navarro; J M Ribera; A Oriol; M Vaquero; J Romeu; M Batlle; A Flores; F Millá; E Feliu
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

2.  ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma.

Authors: 
Journal:  Ann Oncol       Date:  2001-09       Impact factor: 32.976

Review 3.  Opt in or opt out: what is optimal for prenatal screening for HIV infection?

Authors:  Sharon Walmsley
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

4.  Reducing the length of time between HIV infection and diagnosis.

Authors:  Catherine Dodds; Peter Weatherburn
Journal:  BMJ       Date:  2007-06-30

5.  Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test.

Authors:  W M Simpson; F D Johnstone; F M Boyd; D J Goldberg; G J Hart; R J Prescott
Journal:  BMJ       Date:  1998-01-24

6.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

7.  Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Authors:  Lawrence D Kaplan; Jeannette Y Lee; Richard F Ambinder; Joseph A Sparano; Ethel Cesarman; Amy Chadburn; Alexandra M Levine; David T Scadden
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

8.  Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

Authors:  Henry Masur; Jonathan E Kaplan; King K Holmes
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

Review 9.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411
  9 in total
  5 in total

1.  Time for oncologists to opt in for routine opt-out HIV testing?

Authors:  Elizabeth Y Chiao; Bruce J Dezube; Susan E Krown; William Wachsman; Malcolm V Brock; Thomas P Giordano; Ronald Mitsuyasu; Liron Pantanowitz
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

2.  HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center.

Authors:  Jessica P Hwang; Bruno P Granwehr; Harrys A Torres; Maria E Suarez-Almazor; Thomas P Giordano; Andrea G Barbo; Heather Y Lin; Michael J Fisch; Elizabeth Y Chiao
Journal:  J Oncol Pract       Date:  2015-08-04       Impact factor: 3.840

3.  HIV testing practices by clinical service before and after revised testing guidelines in a Swiss University Hospital.

Authors:  Katharine E A Darling; Olivier Hugli; Rachel Mamin; Cristina Cellerai; Sebastien Martenet; Alexandre Berney; Solange Peters; Renaud A Du Pasquier; Patrick Bodenmann; Matthias Cavassini
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

4.  HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study.

Authors:  Mazvita Sengayi; Chantal Babb; Matthias Egger; Margaret I Urban
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

5.  Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States.

Authors:  Jun Li; Trevor D Thompson; Eric Tai; Guixiang Zhao; Alexandra M Oster
Journal:  Prev Chronic Dis       Date:  2014-11-13       Impact factor: 2.830
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.